“showed a trend”

IPC showed a trend toward lowering the DVT risk compared to the control group, but this difference was not significant (OR, 0.50; 95% CrI, 0.20–1.23) ( Supplementary Table 3 ).

Despite the fact that our results showed a trend of decreasing net charges compared to the monthly average of the prediet period, negative costs, which indicate net savings, were achieved 9 months after starting the diet and were maintained afterwards.

A recent study of patients with metastatic CRC harboring wild-type KRAS showed a trend towards improved PFS in patients with wild-type PIK3CA compared to PI3KCA -mutant patients who received cetuximab either as a monotherapy or in combination with chemotherapy ( P = 0.06)[ 68 ].

However, the effect was partial and showed a trend but did not reach statistical significance in this small single‐center study.

Changes in macrophages showed a trend similar to those in total cells in all groups except the OVA + ZymA group, which showed a significant increase over the OVA-only group.

The same difference was not apparent for area measurements, and purebred Arabians even showed a trend towards highest values.

Survival curves for arteries in the abdominal territories also showed a trend towards reduced survival, but only SMA and CIA calcium were associated with significantly lower survival in comparison to those without calcification ( p < 0.01).

Regulatory T cells (Tregs) also showed a trend towards higher numbers in CS-exposed aged mice, while there were no changes for Th1 cells for both young and old animals after CS exposure.

Mice that received T plus B cells compared with T cells alone showed a trend towards reduced ability to control tumor growth after day 50, although the effect failed to reach statistical significance ( p = 0.0516) (Figure 1B ).

FIB4 and APRI merely showed a trend toward these variables (Table 2 ).

Higher mannitol doses (g/kg/day) showed a trend for increasing the risk, but the effect was not significant ( P = 0.053).

Following the operation, all DTI parameters showed a trend toward normalization, yet differences from the values of healthy control subjects remained.

FZD6 expression alone showed a trend towards shorter patient survival, but did not reach statistical significance (log-rank test, P =0.137), unless it was combined with miR-20b expression ( Supplementary Fig. 14c,d ).

The EPC-2 cells showed a trend that was consistent with the finding in the co-culture experiment with a decrease in the proliferation rate in conditioned vs. regular media ( Fig. 6A , Table 1 ).

A novel growth factor, CLEC11A/SCGF-b, which to our knowledge has not yet been associated with senescence yet, showed a trend for increased secretion in shS2 cells.

Among the selected targets, Thy1 (LTR/Gypsy), Parp4 (LTR/Gypsy) and Hel1 (RC/Helitron) all showed a trend of reduced expression with the progression of development.

“Increased vividness” [ χ 2 (2, n = 15) = 5.20, p = 0.074] showed a trend towards significance.

Interestingly, consistent with previous studies, lower levels of 25(OH)D showed a trend toward higher inflammatory markers in our cohort (albeit not statistically significant).

Combined exposure of endothelial cells to VEGF‐A and ANG‐1 showed a trend to reduce ANG‐2 production induced by VEGF‐A (Fig 1 D).

Subsequent 2-sample t tests for this ROI showed a trend for greater SFG activation in the MPH group compared to the placebo group ( t (25) = 2.81, P FWE = .09) at the second fMRI appointment, while no significant differences were observed at the first appointment (all P FWE > .1).

This group with slower baseline gait speed showed a trend for greater improvement in delta gait speed for pre vs. post-intervention (R 2 = 0.3906).

In the LPS-treated slices, the density of IL-1β-positive cells showed a trend for an increase soon after the LPS exposure (2–3.5 h) and increased significantly during the later periods (3.5–5.5 and 5.5–7 h) after the LPS exposure (Fig. 4b ).

There was a lower risk of definite/probable stent thrombosis with long term DAPT among patients with (0.26, 0.09 to 0.80; P=0.02) than without (1.42, 0.68 to 2.98; P=0.35) diabetes, with positive interaction testing (P=0.04 for interaction), although the landmark analysis showed a trend towards benefit in both groups.

The level of hydroxyproline showed a trend towards reduction with fluticasone and combined fluticasone and nilotinib treatment.

Within U-CLL, EZH2 high cases showed a trend for shorter TTFT compared to EZH2 low cases, though not reaching statistical significance (EZH2 high median TTFT = 1.7, EZH2 low median TTFT = 3.3 years, p = 0.14), likely due to the low number of U-CLL EZH2 low cases ( n = 18) ( Supplementary Figure 8 ) DISCUSSION We recently showed that EZH2 is overexpressed in stereotyped CLL subset #1, a paradigmatic aggressive stereotyped subset of CLL cases displaying a distinctive immune signalling profile.